| NCT ID | NCT07145411 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ossium Health, Inc. |
| Condition | Bone Marrow Transplant (BMT) |
| Study Type | OBSERVATIONAL |
| Enrollment | 10 participants |
| Start Date | 2024-06-27 |
| Primary Completion | 2027-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 10 participants in total. It began in 2024-06-27 with a primary completion date of 2027-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Ossium recognizes that not all patients who could benefit from Ossium's HPC, Marrow can access the PRESERVE trial for logistical or eligibility reasons. The HOPE program is expanded access program to serve these patients by providing our bone marrow product
Eligibility Criteria
Inclusion Criteria: Patients aged 12-80 may be eligible\* to receive bone marrow for transplantation through the Ossium HOPE Program if: Their treating physician determined they are eligible for allogeneic bone marrow transplant Their treating physician determined that the potential benefit outweighs the potential risks
Contact & Investigator
Preethi Prasad, Senior Director Clinical Operations
✉ preethi.prasad@ossiumhealth.com📞 415-513-5535
Frequently Asked Questions
Who can join the NCT07145411 clinical trial?
This trial is open to participants of all sexes, aged 12 Years or older, up to 80 Years, studying Bone Marrow Transplant (BMT). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07145411 currently recruiting?
Yes, NCT07145411 is actively recruiting participants. Contact the research team at preethi.prasad@ossiumhealth.com for enrollment information.
Where is the NCT07145411 trial being conducted?
This trial is being conducted at Birmingham, United States, Detroit, United States, Columbus, United States, Nashville, United States.
Who is sponsoring the NCT07145411 clinical trial?
NCT07145411 is sponsored by Ossium Health, Inc.. The trial plans to enroll 10 participants.